Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites

A. A. Kramerov, M. Saghizadeh, S. Caballero, L. C. Shaw, S. Li Calzi, M. Bretner, M. Montenarh, L. A. Pinna, M. B. Grant, A. V. Ljubimov

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Ubiquitous protein kinase CK2 participates in a variety of key cellular functions. We have explored CK2 involvement in angiogenesis. As shown previously, CK2 inhibition reduced endothelial cell proliferation, survival and migration, tube formation, and secondary sprouting on Matrigel. Intraperitoneally administered CK2 inhibitors significantly reduced preretinal neovascularization in a mouse model of proliferative retinopathy. In this model, CK2 inhibitors had an additive effect with somatostatin analog, octreotide, resulting in marked dose reduction for the drug to achieve the same effect. CK2 inhibitors may thus emerge as potent future drugs aimed at inhibiting pathological angiogenesis. Immunostaining of the retina revealed predominant CK2 expression in astrocytes. In human diabetic retinas, mRNA levels of all CK2 subunits decreased, consistent with increased apoptosis. Importantly, a specific CK2 inhibitor prevented recruitment of bone marrow-derived hematopoietic stem cells to areas of retinal neovascularization. This may provide a novel mechanism of action of CK2 inhibitors on newly forming vessels.

Original languageEnglish (US)
Pages (from-to)177-186
Number of pages10
JournalMolecular and Cellular Biochemistry
Volume316
Issue number1-2
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Retinal Neovascularization
Casein Kinase II
Hematopoietic Stem Cells
Stem cells
Retina
Pathologic Neovascularization
Octreotide
Endothelial cells
Cell proliferation
Somatostatin
Astrocytes
Pharmaceutical Preparations
Cell Movement
Cell Survival
Bone
Endothelial Cells
Bone Marrow
Cell Proliferation
Apoptosis
Messenger RNA

Keywords

  • Astrocyte
  • CK2
  • Diabetes
  • DRB
  • Emodin
  • Endothelial
  • Hematopoietic stem cell
  • Neovascularization
  • Retina
  • TBB
  • TBCA

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Kramerov, A. A., Saghizadeh, M., Caballero, S., Shaw, L. C., Li Calzi, S., Bretner, M., ... Ljubimov, A. V. (2008). Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. Molecular and Cellular Biochemistry, 316(1-2), 177-186. https://doi.org/10.1007/s11010-008-9831-4

Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. / Kramerov, A. A.; Saghizadeh, M.; Caballero, S.; Shaw, L. C.; Li Calzi, S.; Bretner, M.; Montenarh, M.; Pinna, L. A.; Grant, M. B.; Ljubimov, A. V.

In: Molecular and Cellular Biochemistry, Vol. 316, No. 1-2, 2008, p. 177-186.

Research output: Contribution to journalArticle

Kramerov, AA, Saghizadeh, M, Caballero, S, Shaw, LC, Li Calzi, S, Bretner, M, Montenarh, M, Pinna, LA, Grant, MB & Ljubimov, AV 2008, 'Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites', Molecular and Cellular Biochemistry, vol. 316, no. 1-2, pp. 177-186. https://doi.org/10.1007/s11010-008-9831-4
Kramerov, A. A. ; Saghizadeh, M. ; Caballero, S. ; Shaw, L. C. ; Li Calzi, S. ; Bretner, M. ; Montenarh, M. ; Pinna, L. A. ; Grant, M. B. ; Ljubimov, A. V. / Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites. In: Molecular and Cellular Biochemistry. 2008 ; Vol. 316, No. 1-2. pp. 177-186.
@article{a31eb0b93f5d4990a742246933808c8e,
title = "Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites",
abstract = "Ubiquitous protein kinase CK2 participates in a variety of key cellular functions. We have explored CK2 involvement in angiogenesis. As shown previously, CK2 inhibition reduced endothelial cell proliferation, survival and migration, tube formation, and secondary sprouting on Matrigel. Intraperitoneally administered CK2 inhibitors significantly reduced preretinal neovascularization in a mouse model of proliferative retinopathy. In this model, CK2 inhibitors had an additive effect with somatostatin analog, octreotide, resulting in marked dose reduction for the drug to achieve the same effect. CK2 inhibitors may thus emerge as potent future drugs aimed at inhibiting pathological angiogenesis. Immunostaining of the retina revealed predominant CK2 expression in astrocytes. In human diabetic retinas, mRNA levels of all CK2 subunits decreased, consistent with increased apoptosis. Importantly, a specific CK2 inhibitor prevented recruitment of bone marrow-derived hematopoietic stem cells to areas of retinal neovascularization. This may provide a novel mechanism of action of CK2 inhibitors on newly forming vessels.",
keywords = "Astrocyte, CK2, Diabetes, DRB, Emodin, Endothelial, Hematopoietic stem cell, Neovascularization, Retina, TBB, TBCA",
author = "Kramerov, {A. A.} and M. Saghizadeh and S. Caballero and Shaw, {L. C.} and {Li Calzi}, S. and M. Bretner and M. Montenarh and Pinna, {L. A.} and Grant, {M. B.} and Ljubimov, {A. V.}",
year = "2008",
doi = "10.1007/s11010-008-9831-4",
language = "English (US)",
volume = "316",
pages = "177--186",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites

AU - Kramerov, A. A.

AU - Saghizadeh, M.

AU - Caballero, S.

AU - Shaw, L. C.

AU - Li Calzi, S.

AU - Bretner, M.

AU - Montenarh, M.

AU - Pinna, L. A.

AU - Grant, M. B.

AU - Ljubimov, A. V.

PY - 2008

Y1 - 2008

N2 - Ubiquitous protein kinase CK2 participates in a variety of key cellular functions. We have explored CK2 involvement in angiogenesis. As shown previously, CK2 inhibition reduced endothelial cell proliferation, survival and migration, tube formation, and secondary sprouting on Matrigel. Intraperitoneally administered CK2 inhibitors significantly reduced preretinal neovascularization in a mouse model of proliferative retinopathy. In this model, CK2 inhibitors had an additive effect with somatostatin analog, octreotide, resulting in marked dose reduction for the drug to achieve the same effect. CK2 inhibitors may thus emerge as potent future drugs aimed at inhibiting pathological angiogenesis. Immunostaining of the retina revealed predominant CK2 expression in astrocytes. In human diabetic retinas, mRNA levels of all CK2 subunits decreased, consistent with increased apoptosis. Importantly, a specific CK2 inhibitor prevented recruitment of bone marrow-derived hematopoietic stem cells to areas of retinal neovascularization. This may provide a novel mechanism of action of CK2 inhibitors on newly forming vessels.

AB - Ubiquitous protein kinase CK2 participates in a variety of key cellular functions. We have explored CK2 involvement in angiogenesis. As shown previously, CK2 inhibition reduced endothelial cell proliferation, survival and migration, tube formation, and secondary sprouting on Matrigel. Intraperitoneally administered CK2 inhibitors significantly reduced preretinal neovascularization in a mouse model of proliferative retinopathy. In this model, CK2 inhibitors had an additive effect with somatostatin analog, octreotide, resulting in marked dose reduction for the drug to achieve the same effect. CK2 inhibitors may thus emerge as potent future drugs aimed at inhibiting pathological angiogenesis. Immunostaining of the retina revealed predominant CK2 expression in astrocytes. In human diabetic retinas, mRNA levels of all CK2 subunits decreased, consistent with increased apoptosis. Importantly, a specific CK2 inhibitor prevented recruitment of bone marrow-derived hematopoietic stem cells to areas of retinal neovascularization. This may provide a novel mechanism of action of CK2 inhibitors on newly forming vessels.

KW - Astrocyte

KW - CK2

KW - Diabetes

KW - DRB

KW - Emodin

KW - Endothelial

KW - Hematopoietic stem cell

KW - Neovascularization

KW - Retina

KW - TBB

KW - TBCA

UR - http://www.scopus.com/inward/record.url?scp=50649090911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50649090911&partnerID=8YFLogxK

U2 - 10.1007/s11010-008-9831-4

DO - 10.1007/s11010-008-9831-4

M3 - Article

VL - 316

SP - 177

EP - 186

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -